Page last updated: 2024-08-23

etoposide and fk 866

etoposide has been researched along with fk 866 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boldorini, R; Canonico, PL; Di Lisa, F; Drago, V; Galli, U; Genazzani, AA; Kaludercic, N; Maldi, E; Travelli, C; Tron, GC1

Other Studies

1 other study(ies) available for etoposide and fk 866

ArticleYear
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 338, Issue:3

    Topics: Acrylamides; Adenosine; Adenosine Triphosphate; Annexin A5; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Autophagy; Autophagy-Related Protein 7; Cell Death; Cell Line, Tumor; Cell Nucleus; Cell Survival; Chloroquine; Cisplatin; Comet Assay; DNA Damage; Down-Regulation; Drug Synergism; Etoposide; Humans; Immunohistochemistry; L-Lactate Dehydrogenase; Neuroblastoma; Nicotinamide Phosphoribosyltransferase; Piperidines; Ubiquitin-Activating Enzymes

2011